Reg Malmberg

Reg Malmberg currently serves as the Chief Financial Officer at PureTech Scientific, where the company recently completed an acquisition of the Glycolic Acid business from The Chemours Company, thus enhancing its position in the organic synthesis market. Prior to this role, Malmberg held several key financial positions at The Chemours Company, including Vice President of Finance and Global Finance Director, as well as serving on the board of Chemours Chenguang Fluoromaterials. Malmberg's earlier experience includes positions at DuPont and DuPont Teijin Films, where responsibilities spanned multiple regions. Malmberg holds an M.B.A. in Finance from the University of Utah and a Bachelor's Degree in Agricultural Economics from the University of Wyoming.